Franklin Resources’s Cullinan Oncology CGEM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $16.8M | Buy |
2,228,160
+8,399
| +0.4% | +$63.2K | ﹤0.01% | 973 |
|
|
2025
Q1 | $16.8M | Buy |
2,219,761
+20,052
| +0.9% | +$152K | ﹤0.01% | 948 |
|
|
2024
Q4 | $26.8M | Buy |
2,199,709
+8,447
| +0.4% | +$103K | 0.01% | 810 |
|
|
2024
Q3 | $35.6M | Sell |
2,191,262
-252,868
| -10% | -$4.1M | 0.01% | 701 |
|
|
2024
Q2 | $42.6M | Sell |
2,444,130
-252,632
| -9% | -$4.41M | 0.01% | 594 |
|
|
2024
Q1 | $46M | Sell |
2,696,762
-584,518
| -18% | -$9.96M | 0.01% | 595 |
|
|
2023
Q4 | $33.4M | Buy |
3,281,280
+390,505
| +14% | +$3.98M | 0.02% | 623 |
|
|
2023
Q3 | $26.2M | Buy |
2,890,775
+556,689
| +24% | +$5.04M | 0.01% | 669 |
|
|
2023
Q2 | $25.1M | Buy |
2,334,086
+1,544,948
| +196% | +$16.6M | 0.01% | 707 |
|
|
2023
Q1 | $8.07M | Buy |
789,138
+7,012
| +0.9% | +$71.7K | ﹤0.01% | 977 |
|
|
2022
Q4 | $8.25M | Sell |
782,126
-3,093
| -0.4% | -$32.6K | ﹤0.01% | 986 |
|
|
2022
Q3 | $10.1M | Buy |
785,219
+6,137
| +0.8% | +$78.7K | 0.01% | 928 |
|
|
2022
Q2 | $9.99M | Buy |
779,082
+1,202
| +0.2% | +$15.4K | 0.01% | 954 |
|
|
2022
Q1 | $8.14M | Buy |
777,880
+3,346
| +0.4% | +$35K | ﹤0.01% | 1065 |
|
|
2021
Q4 | $12M | Sell |
774,534
-1,872
| -0.2% | -$28.9K | ﹤0.01% | 1008 |
|
|
2021
Q3 | $17.5M | Sell |
776,406
-1,092
| -0.1% | -$24.6K | 0.01% | 918 |
|
|
2021
Q2 | $20M | Buy |
777,498
+289,190
| +59% | +$7.45M | 0.01% | 854 |
|
|
2021
Q1 | $20.3M | Buy |
+488,308
| New | +$20.3M | 0.01% | 831 |
|